2021 annual financial data
Lexeo Therapeutics 2021 Operating margin
Direct answer
Operating margin was -3,055.94%.
Operating income was -50,637,000 USD and net income was -50,622,000 USD.
Operating cash flow was -44,182,000 USD.
Get free Lexeo Therapeutics email updates.
Bullstory sends one daily email when new analysis or important company news is available.
Verified data
- Revenue
- 1,657,000 USD
- Operating income
- -50,637,000 USD
- Net income
- -50,622,000 USD
- Operating cash flow
- -44,182,000 USD